• Shopping cart is empty.

    The International Society for Aerosols in Medicine

    Giovanni Viegi

    Giovanni Viegi

    Giovanni Viegi

    CNR Institutes of Biomedicine and Molecular Immunology, Palermo,
    and of Clinical Physiology
    Pisa, Italy

    Giovanni Viegi, MD, FERS. Acting Director of CNR Institute of Biomedicine and Molecular Immunology “A. Monroy”, Palermo (Italy). Fellow of the European Respiratory Society. Member of the Environmental, Occupational and Population Health Planning Committee of the American Thoracic Society. Member of the Global Alliance Against chronic Respiratory Diseases Planning Group within the World Health Organization. President of the European Respiratory Society in 2005-2006.


    Global burden of chronic respiratory diseases

    Abstract

    Most recent information derive from the Global Burden of Disease Study 2017 reports. There were 3914200 deaths due to chronic obstructive pulmonary disease (COPD) and 495100 to asthma. COPD was the 7th leading cause of years of life lost (YLLs).Prevalence and incidence of COPD were 299398200 and 18475700, those of asthma 272677500 and 43123400 cases. COPD ranked 6th in females and 9th in males for years lived with disability. COPD accounted for 81600000 disability-adjusted life-years (DALYs), asthma for 22800000. COPD ranked 6th in both sexes, asthma 30th in females and 32nd in males for DALYs. Among risk factors, a relevant role was played by smoking and high body mass index for asthma, by smoking, particulate matter pollution, ambient ozone pollution, occupational particulate matter, gases and fumes, as well as by second-hand smoke for COPD. Forecasting YLLs by 2040 showed a rising toll from several non-communicable diseases (NCDs) due to population growth and aging: COPD will rank 4th. COPD prevalence of 9.1% has been found in a recent general population sample of North-Eastern Italy, whilst in Central Italy a 25 yr follow-up of a general population sample has shown an increased prevalence of COPD and asthma symptoms/diseases. A strategy for measuring health outcomes and evaluating impacts of interventions on asthma and COPD has been recently published by the Global Alliance against chronic Respiratory Diseases (GARD).